Monday, 28 September 2026Updated 15m ago
← Top stories
Deal▲ Bullish for Sun Pharma

Sun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.

2 sources · first seen 09:04 28 Sept · updated 10:01 28 Sept

The brief

Written from 3 reports · check the source before you trade
  • Sun Pharma secured exclusive rights to commercialize and manufacture Lerodalcibep worldwide, excluding the US and China
  • The licensing deal gives Sun Pharma a potential global product opportunity outside the US and China

Tags on this story

Pick a tag to see all its stories
Sun Pharma₹1,852.20 · 2 todayPharma and healthcare17 todayChina24 today

Read the reports

3 reports · earliest 09:04
Business StandardSun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.09:04CNBC-TV18Sun Pharma inks global licensing deal with LIB Therapeutics for bad cholesterol treatment drug09:12Business StandardSun Pharma bags rights to $3.7 billion cholesterol drug market globally10:01